Answer
The most frequently reported adverse reactions to secukinumab are upper respiratory tract infections (17.1%), most frequently nasopharyngitis and rhinitis.
Sources for this answer
- Cosentyx 150mg and 300mg solution for injection in pre-filled syringe and pre-filled penNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.8 Undesirable effects · Version 29Document updated
Sources checked